Anebulo Pharmaceuticals, Inc. (ANEB) Earnings
|
Expand Research on ANEB
| Next EPS Date | 9/17/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +42.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/26  |
Q326 | N/A | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/12/26 | Q226 | -$0.05 | -$0.13 | +$0.08 | N/A | N/A | N/A |  | | Details | |
| 2/10/26 |
Q226 | N/A | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/9/26 |
Q226 | N/A | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/6/26 |
Q226 | N/A | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q126 | N/A | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/25 |
Q126 | N/A | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/11/25 |
Q126 | N/A | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A |
